Sanofi Purchases Provention Bio for $2.9B
Sanofi will get a new medicine to complement its older diabetes therapies based on insulin.
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.